Roblitinib T4235
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
FGF401 is an inhibitor of human fibroblast growth factor receptor 4 (FGFR4), with potential antineoplastic activity. Upon administration, FGF401 binds to and inhibits the activity of FGFR4, which leads to an inhibition of tumor cell proliferation in FGFR4
CAS nr:
1708971-55-4
Purity:
98%
Molecular Weight:
506,57
SMILES:
COCCNc1cc(ncc1C#N)NC(=O)N1CCCc2c1nc(C=O)c(c2)CN1CCN(CC1=O)C
Formula:
C25H30N8O4
Pathway:
Tyrosine Kinase/Adaptors,Angiogenesis
Target:
FGFR,FGFR
